title: 4-Aminopyridine improves gait variability in cerebellar ataxia due to CACNA 1A mutation.
authors: Roman
authors: R
authors: Schniepp
authors: Max
authors: M
authors: Wuehr
authors: Nibal
authors: N
authors: Ackl
authors: Adrian
authors: A
authors: Danek
authors: Thomas
authors: T
authors: Brandt
authors: Michael
authors: M
authors: Strupp
authors: Klaus
authors: K
authors: Jahn
mesh_terms: D015761:4-Aminopyridine / Q000494:pharmacology* / Q000627:therapeutic use; D000368:Aged; D015220:Calcium Channels / Q000235:genetics*; D002524:Cerebellar Ataxia / Q000150:complications / Q000188:drug therapy* / Q000235:genetics*; D020233:Gait Disorders, Neurologic / Q000188:drug therapy* / Q000209:etiology / Q000235:genetics; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000235:genetics*; D026902:Potassium Channel Blockers / Q000494:pharmacology / Q000627:therapeutic use; D020864:Calcium Channels, N-Type
chemical_list: D015761:4-Aminopyridine; D015220:Calcium Channels; D026902:Potassium Channel Blockers; C105656:CACNA1A protein, human; D020864:Calcium Channels, N-Type